Concepedia

N. Bradly Glazer

NB

Statistics

Publications

7

Citations

713

H-Index

7

Active since

1999

Affiliations

Takeda (United States)(Current)

Eli Lilly (United States)

N. Bradly Glazer is an author at Takeda (United States) specializing in diabetes, medicine, and pharmacology.

Top concepts

Publications per year

1999–2004

7

Publications

7

The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus

Sidney Rosenblatt, Barry Miskin, N. Bradly Glazer et al. · Coronary Artery Disease · 2001 · 220 citations

Pioglitazone Reduces Atherogenic Index of Plasma in Patients with Type 2 Diabetes

Meng H. Tan, Don Johns, N. Bradly Glazer · Clinical Chemistry · 2004 · 207 citations · Full text

EFFICACY AND SAFETY OF PIOGLITAZONE IN TYPE 2 DIABETES: A RANDOMISED, PLACEBO‐CONTROLLED STUDY IN PATIENTS RECEIVING STABLE INSULIN THERAPY

Julio Rosenstock, Daniel Einhorn, Kenneth S. Hershon et al. · International Journal of Clinical Practice · 2002 · 193 citations · Full text

, , +12

Combination therapy with pioglitazone plus metformin or sulfonylurea in patients with Type 2 diabetes

Marc Rendell, N. Bradly Glazer, Zhan Ye · Journal of Diabetes and its Complications · 2003 · 39 citations

, , +6

Pioglitazone as monotherapy or in combination with sulfonylurea or metformin enhances insulin sensitivity (HOMA-S or QUICKI) in patients with type 2 diabetes

Meng H. Tan, N. Bradly Glazer, Don Johns et al. · Current Medical Research and Opinion · 2004 · 25 citations

1–5 of 7